{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-033314","form_type":"8-K","ticker":"BIXT","cik":"0001445815","company_name":"BIOXYTRAN, INC","filed_at":"2024-08-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.088660+00:00","generated_at":"2026-05-31T08:27:05.266579+00:00","sec_items":["3.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bioxytran issues 28.97M preferred shares to insiders, converts 94M common shares and $354K debt","bullets":["Issued 28,971,248 convertible preferred shares to insiders in exchange for 94,057,658 common shares at a 5:1 ratio.","Preferred shares have super voting rights: vote on 'as if converted' basis multiplied by 2; insiders now control 77.9% voting power.","Conversion also extinguished $353,840 in accrued salaries, accounts receivable, and short-term debt plus 14.41M subsidiary shares.","Common shares outstanding reduced to 81,850,495; par value $0.001 per share; listed on OTCQB.","Press release announces peer-reviewed British Journal article on carbon monoxide in mitochondria, using MDX Viewer to validate BXT-25."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-033314","json":"https://secwatch.observer/filing/0001493152-24-033314.json","markdown":"https://secwatch.observer/filing/0001493152-24-033314.md","text":"https://secwatch.observer/filing/0001493152-24-033314.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1445815/000149315224033314/0001493152-24-033314-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1445815/000149315224033314/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:27:05.266579+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}